Prellisbio
Hayward, US · Delaware corporation · 9 known investors
Prellis develops an AI-enabled platform for antibody discovery using 3D-printed organoids that recapture human immune biology, generating therapeutic antibody candidates for multiple disease areas. The platform combines machine learning with wet lab characterization to accelerate the development of fully human antibody therapeutics.
Founders & leadership
AG
Arvind GuptaDirector
MM
Melanie MatheuExecutive Officer, Director
NM
Noelle MullinExecutive Officer, Director
RS
Rohit SharmaDirector
Investors · 9
Black Diamond VenturesGlendale · $2M – $10M
Civilization Ventures Management, LlcTiburon · $1M – $10M
Open Field CapitalNew York
Prefix CapitalSan Francisco
Cantos VenturesreportedSan Francisco · $400K – $1.5M
Celesta CapitalreportedMenlo Park · $5M – $20M
Khosla VenturesreportedMenlo Park · $5K – $50Mvia Alex Morgan · board
SOSVreportedNew York · $30K – $550K
True VenturesreportedSan Francisco · $500K – $3Mvia Rohit Sharma · board
Reported raises · per SEC filings
Form D private placements▶$17MraisedJul 2022 · 19 investors · Other TechnologyRule 506(b)
▶$17MraisedJul 2022 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael MarksDirector
- Sean O'SullivanDirector
- Melanie MatheuExecutive Officer, Director
- Alex MorganDirector
- Shaun HoltDirector
- Lei MengDirector
- Offering amount
- $35M
- Amount sold
- $17M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$19.3MraisedJul 2021 · 9 investors · Other TechnologyRule 506(b)
▶$19.3MraisedJul 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Arvind GuptaDirector
- Michael MarksDirector
- Shaun HoltDirector
- Alex MorganDirector
- Melanie MatheuExecutive Officer, Director
- Offering amount
- $19.3M
- Amount sold
- $19.3M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$8.7MraisedMar 2019 · 11 investors · Other TechnologyRule 506(b)
▶$8.7MraisedMar 2019 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Melanie MatheuExecutive Officer, Director
- Rohit SharmaDirector
- Arvind GuptaDirector
- Offering amount
- $9.2M
- Amount sold
- $8.7M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$460KraisedFeb 2018 · 2 investors · BiotechnologyRule 506(b)
▶$460KraisedFeb 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Arvind GuptaDirector
- Melanie MatheuExecutive Officer, Director
- Noelle MullinExecutive Officer, Director
- Rohit SharmaDirector
- Offering amount
- $1M
- Amount sold
- $460K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.8MraisedJul 2017 · 2 investors · Other TechnologyRule 506(b)
▶$1.8MraisedJul 2017 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Noelle MullinExecutive Officer, Director
- Melanie MatheuExecutive Officer, Director
- Arvind GuptaDirector
- Rohit SharmaDirector
- Offering amount
- $2.1M
- Amount sold
- $1.8M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.